Peer-Reviewed Study: bioAffinity Technologies CyPath Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications.

Press/Media

Period20 Sep 2024

Media coverage

1

Media coverage

  • TitlePeer-Reviewed Study: bioAffinity Technologies CyPath Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications.
    Media name/outletImpact Financial News
    Country/TerritoryUnited Kingdom
    Date20/09/24
    PersonsMichael Morris
View all 1
View less